Dear Cochrane friends and colleagues,
I am writing to you with my fortnightly summary of Cochrane’s COVID-19 work, for 9-20 November 2020.
- On 20 November, we published an Editorial Policy makers must act on incomplete evidence in responding to COVID-19. It addresses how Cochrane has responded to the COVID-19 pandemic, what the limitations to COVID-19 evidence are, and suggestions on how policy makers can move forward with best available evidence. Read the full Editorial on the Cochrane Library.
- On 20 November, Cochrane Acute Respiratory Infections Group published the updated review Physical interventions to interrupt or reduce the spread of respiratory viruses. Read the full review on the Cochrane Library.
- On 19 November, Cochrane Infectious Diseases Group published the diagnostic test accuracy review Routine laboratory testing to determine if a patient has COVID-19. Read the full review on the Cochrane Library.
- The authors of the rapid qualitative evidence synthesis “Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases” have published a reflection on the process of completing this review. In it, they praise the collaborative nature of Cochrane and the importance of this when working to extreme deadlines in a pandemic situation. Read the full publication from BMC Systematic Reviews.
- Many new Cochrane Clinical Answers related to COVID-19 have published in recent weeks; view all CCAs for COVID-19.
Stay well and best wishes,
Editor in Chief, Cochrane Library
November 20, 2020